Smith & Nephew plc logo
Smith & Nephew plc SNN
$ 33.1 0.15%

Annual report 2024
added 12-06-2025

report update icon

Smith & Nephew plc Gross Profit 2011-2025 | SNN

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Smith & Nephew plc

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.05 B 3.82 B 3.68 B 3.67 B 3.16 B 3.8 B 3.61 B 3.52 B 3.4 B 3.49 B 3.46 B 3.25 B 3.07 B 3.13 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.05 B 3.07 B 3.51 B

Gross Profit of other stocks in the Medical devices industry

Issuer Gross Profit Price % 24h Market Cap Country
Abiomed Abiomed
ABMD
690 M - - $ 17.2 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
424 M $ 20.95 -0.1 % $ 2.99 B usaUSA
Acutus Medical Acutus Medical
AFIB
-3.14 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
443 K - 3.58 % $ 2.21 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
67.9 M - - $ 1.77 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
247 M $ 9.28 -0.32 % $ 666 M israelIsrael
Apyx Medical Corporation Apyx Medical Corporation
APYX
33.8 M $ 3.54 2.91 % $ 123 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
11.5 B $ 95.79 -0.24 % $ 141 B usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
584 K - -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
342 M $ 303.53 -0.15 % $ 8.56 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
42.4 M - - $ 475 M usaUSA
Conformis Conformis
CFMS
23.2 M - - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
173 M - 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
-12.7 M - -10.19 % $ 1.99 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
229 K - 37.08 % $ 85.7 M usaUSA
Electromed Electromed
ELMD
50 M $ 28.33 -0.6 % $ 240 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
1.65 B $ 48.37 0.74 % $ 7.21 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
18.7 B $ 124.66 -0.14 % $ 217 B usaUSA
Eargo Eargo
EAR
14.3 M - - $ 10.2 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
26.6 M $ 3.25 -4.41 % $ 121 M franceFrance
CryoLife, Inc. CryoLife, Inc.
CRY
168 M - -4.14 % $ 702 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
4.25 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
28.7 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
43.7 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
1.99 M - - $ 111 M canadaCanada
InMode Ltd. InMode Ltd.
INMD
317 M $ 14.81 1.3 % $ 1.17 B israelIsrael
IRIDEX Corporation IRIDEX Corporation
IRIX
21.8 M $ 1.17 -4.88 % $ 18.9 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
56.3 M $ 97.65 0.21 % $ 1.24 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
6.01 M - 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.2 M - - $ 955 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
871 M $ 62.29 -0.93 % $ 3.38 B britainBritain
LENSAR LENSAR
LNSR
14.1 M $ 11.93 -0.21 % $ 137 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
500 K - -0.97 % $ 54.4 M usaUSA
Align Technology Align Technology
ALGN
2.8 B $ 158.32 -0.03 % $ 11.9 B usaUSA
NanoVibronix NanoVibronix
NAOV
1.51 M - - $ 1.08 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
147 M $ 0.81 -1.31 % $ 83.2 M usaUSA
Avinger Avinger
AVGR
2 M - -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
19.1 M $ 13.56 -3.28 % $ 366 M usaUSA
FONAR Corporation FONAR Corporation
FONR
42.4 M $ 14.46 0.07 % $ 94.8 M usaUSA
AxoGen AxoGen
AXGN
142 M $ 33.15 1.07 % $ 1.47 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
198 M - - $ 3.31 B usaUSA
GBS GBS
GBS
1.25 M - -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
733 M $ 41.41 1.57 % $ 1.28 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
149 M $ 17.7 2.08 % $ 408 M usaUSA
Globus Medical Globus Medical
GMED
719 M $ 88.34 -0.08 % $ 12 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
953 M $ 12.58 -0.32 % $ 969 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
11.1 M - 1.37 % $ 20.5 M usaUSA